Fennec Pharmaceuticals (FENC) Files DEF 14A for April 28 Meeting

Fennec Pharmaceuticals Inc. (FENC) submitted its DEF 14A filing, related to the annual meeting scheduled for April 28. This filing typically contains important information regarding corporate governance and potential shareholder proposals. The DEF 14A is required by the SEC and provides insight into the company's management and financial decisions. Such filings can impact investor sentiment and stock performance based on disclosed information.